C. Dürr

发表

Depletion of CLL-associated patrolling monocytes and macrophages controls disease development and repairs immune dysfunction in vivo

J. Gribben, P. Lichter, A. Benner, 2016, Leukemia.

Bio-Activity and Dereplication-Based Discovery of Ophiobolins and Other Fungal Secondary Metabolites Targeting Leukemia Cells

J. Frisvad, M. Seiffert, T. O. Larsen, 2013, Molecules.

Fungal natural products targeting chronic lymphocytic leukemia

M. Seiffert, T. O. Larsen, C. Gotfredsen, 2012 .

Lenalidomide reduces survival of chronic lymphocytic leukemia cells in primary cocultures by altering the myeloid microenvironment.

H. Döhner, P. Lichter, S. Stilgenbauer, 2012, Blood.

primary co-cultures by altering the myeloid microenvironment Lenalidomide reduces survival of chronic lymphocytic leukemia cells in

H. Döhner, P. Lichter, S. Stilgenbauer, 2013 .

Isolation, Structural Analyses and Biological Activity Assays against Chronic Lymphocytic Leukemia of Two Novel Cytochalasins — Sclerotionigrin A and B

J. Frisvad, M. Seiffert, T. O. Larsen, 2014, Molecules.

Synthesis, enzymatic stability and in vitro cytostatic effect of Daunorubicin-GnRH-III derivative dimers.

G. Mező, A. Marquardt, E. Orbán, 2013, Bioorganic & medicinal chemistry letters.

Dissecting the Prognostic Significance and Functional Role of Progranulin in Chronic Lymphocytic Leukemia

P. Lichter, S. Stilgenbauer, A. Benner, 2019, Cancers.

Tumor necrosis factor receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid wogonin

J. Gribben, P. Lichter, S. Stilgenbauer, 2018, Haematologica.

Targeting dysfunctional myeloid cells delays disease development and improves immune function in a CLL mouse model (TUM6P.1009)

J. Gribben, P. Lichter, V. Kalter, 2014, Journal of Immunology.